BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2744630)

  • 1. Thrombin activity and oral anticoagulant therapy: a preliminary study.
    Marongiu F; Sorano GG; Mameli G; Mamusa AM; Cambuli AB; Conti M; Sanna MP; Farci P; Balestrieri A
    Haemostasis; 1989; 19(3):142-6. PubMed ID: 2744630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
    Harenberg J; Haas R; Zimmermann R
    Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal therapeutic range for oral anticoagulant treatment as suggested by fibrinopeptide A (FpA) levels in patients with heart valve prostheses.
    Pengo V; Peruzzi P; Baca M; Marzari A; Zanon F; Schivapappa L; Dalla Volta S
    Eur J Clin Invest; 1989 Apr; 19(2):181-4. PubMed ID: 2499477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
    Barcellona D; Vannini ML; Fenu L; Balestrieri C; Marongiu F
    Thromb Haemost; 1998 Dec; 80(6):899-902. PubMed ID: 9869157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.
    Musial J; Brzezinska-Kolarz B; Zólcinski M; Lelakowski J; Szczeklik A
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):614-21. PubMed ID: 20460350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Checking oral anticoagulation in capillary blood].
    Navarro JL; César JM; García Frade LJ; Pardo A; Avello AG; Trejo R; Villarrubia J; López J
    Sangre (Barc); 1994 Aug; 39(4):257-60. PubMed ID: 7985054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled vitamin K content diet for improving the management of poorly controlled anticoagulated patients: a clinical practice proposal.
    Sorano GG; Biondi G; Conti M; Mameli G; Licheri D; Marongiu F
    Haemostasis; 1993; 23(2):77-82. PubMed ID: 8365689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease.
    Yoda Y; Abe T
    Thromb Haemost; 1981 Dec; 46(4):706-9. PubMed ID: 7330820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon.
    Fihn SD; Gadisseur AA; Pasterkamp E; van der Meer FJ; Breukink-Engbers WG; Geven-Boere LM; van Meegen E; de Vries-Goldschmeding H; Antheunissen-Anneveld I; van't Hoff AR; Harderman D; Smink M; Rosendaal FR
    Thromb Haemost; 2003 Aug; 90(2):260-6. PubMed ID: 12888873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indices of fibrinogen proteolysis and platelet activation during the resolution of pulmonary embolism.
    Yudelman I
    Thromb Haemost; 1987 Feb; 57(1):11-6. PubMed ID: 2954258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio.
    Ignjatovic V; Barnes C; Newall F; Hamilton S; Burgess J; Monagle P
    Thromb Haemost; 2004 Oct; 92(4):734-7. PubMed ID: 15467903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of drug interactions with single dose acenocoumarol: new screening method?
    Kroon C; de Boer A; Hoogkamer JF; Schoemaker HC; van der Meer EJ; Edelbroek PM; Cohen AF
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):355-60. PubMed ID: 2272718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinopeptide A during normal pregnancy.
    Romero R; Rickles FR; Matthews E; Scott D; Dinan C; Duffy T
    Am J Perinatol; 1988 Jan; 5(1):70-3. PubMed ID: 3257391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Hydroxycoumarin oral anticoagulants: pharmacokinetics-response relationship.
    Thijssen HH; Hamulyák K; Willigers H
    Thromb Haemost; 1988 Aug; 60(1):35-8. PubMed ID: 3187945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation responses to heparin in the ischemic limb: assessment of thrombin and platelet activation during vascular surgery.
    Sobel M; Gervin CA; Qureshi DG; Greenfield LJ
    Circulation; 1987 Sep; 76(3 Pt 2):III8-13. PubMed ID: 2957118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that factor VII levels correlate strongly with fibrinopeptide A release: evaluation by an ex vivo method.
    Mariani G; Iacopino G; Pasquali-Lasagni R
    Int J Clin Lab Res; 1992; 22(2):111-4. PubMed ID: 1504303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose vitamin K1 versus short-term with holding of acenocoumarol in the treatment of excessive anticoagulation episodes induced by acenocoumarol. A retrospective comparative study.
    Ortín M; Olalla J; Marco F; Velasco N
    Haemostasis; 1998; 28(2):57-61. PubMed ID: 10087429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.